Drug Information

Drug General Information
Drug ID
D06JFN
Former ID
DNC009665
Drug Name
N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529872]
Formula
C18H19BrN2O4S
Canonical SMILES
C1COCCN1S(=O)(=O)C2=C(C=CC(=C2)C(=O)NCC3=CC=CC=C3)Br
InChI
1S/C18H19BrN2O4S/c19-16-7-6-15(18(22)20-13-14-4-2-1-3-5-14)12-17(16)26(23,24)21-8-10-25-11-9-21/h1-7,12H,8-11,13H2,(H,20,22)
InChIKey
DEVYAXBKQQLYGQ-UHFFFAOYSA-N
PubChem Compound ID
1076739
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Inhibitor [529872]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 529872Bioorg Med Chem Lett. 2009 Jan 15;19(2):309-13. Epub 2008 Nov 27.CB2 selective sulfamoyl benzamides: optimization of the amide functionality.
Ref 529872Bioorg Med Chem Lett. 2009 Jan 15;19(2):309-13. Epub 2008 Nov 27.CB2 selective sulfamoyl benzamides: optimization of the amide functionality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.